CNTA

Centessa Pharmaceuticals plc

8.93 USD
+0.06 (+0.68%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Centessa Pharmaceuticals plc stock is down -15.52% since 30 days ago. The next earnings date is Aug 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 3 May’s closed higher than April.

About Centessa Pharmaceuticals plc

Centessa Pharmaceuticals plc discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor. SerpinPC, an activated protein C inhibitor, is in Phase IIa clinical development for the treatment of hemophilia A and B. The company also has emerging pipeline products under clinical proof of concept stage.